# Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency

> **NCT01357460** · NA · TERMINATED · sponsor: **Heidelberg University** · enrollment: 18 (actual)

## Conditions studied

- Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)

## Interventions

- **DEVICE:** Implantation of intrabronchial valves (IBV) (Spiration IBV)

## Key facts

- **NCT ID:** NCT01357460
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2014-09-24
- **Final completion:** 2014-12-30
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** difficult patient recruitment
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357460, "Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01357460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*